KOSPI · 128940
HanmiPharm
Market cap₩5.03T
PER23.17×
PBR3.55×
Foreign ownership12.72%
Avg. analyst target₩678,235
Pension summary
as of Oct 19streak2-day net sell
5D-₩16.4B
20D+₩22.8B
60D-₩15.8B
Foreign 20D-₩51.5B
Inst. 20D+₩57.4B
Pension daily net buy
-Cumulative net buying by investor
-선택 기간의 net buy Total · ₩100M
| Date | Close | Pension funds | Foreign | Institutions | Retail |
|---|---|---|---|---|---|
| 10/19 | 391,000 | -₩5.0B | +₩4.1B | -₩10.4B | +₩6.3B |
| 10/16 | 397,000 | -₩270M | +₩2.2B | -₩70M | -₩2.1B |
| 10/15 | 379,500 | +₩180M | +₩3.7B | +₩2.4B | -₩6.2B |
| 10/14 | 404,000 | -₩6.1B | +₩27.7B | -₩29.8B | +₩5.0B |
| 10/13 | 445,000 | -₩5.2B | +₩12.5B | -₩3.7B | -₩8.7B |
| 10/12 | 466,500 | +₩1.3B | +₩3.3B | +₩4.3B | -₩7.6B |
| 10/8 | 482,000 | +₩7.7B | -₩51.4B | +₩4.0B | +₩47.7B |
| 10/7 | 534,000 | +₩2.0B | -₩13.1B | -₩4.2B | +₩16.5B |
| 10/6 | 529,000 | +₩3.3B | -₩800M | +₩2.1B | -₩1.8B |
| 10/2 | 504,000 | -₩110M | +₩350M | +₩1.1B | -₩1.2B |
Discussion
Google-verified members · return since posting- Loading
Pension cost basis
Oct 19 Close · positions since 2024Pension cost basis497,905
Price vs. cost-21.4%
Holding value₩43.1B
Last 20 days+₩22.8B
Bought in the last 6 months only: avg. cost ₩497,905.
All pension cost data →세력 매집
last 60 trading days · Oct 19Foreign 60D−₩134B
Pension funds 60D−₩15.8B
세력 Avg. cost442,408
vs. cost Close-11.5%
Foreign+Pension funds Total 시총의 -3.0%, 60D price 폭 51%·Chg +5.2%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.
세력 매집 구간 All →Financial score
#98 of KOSPI 50066.2/100
- Value9
- Quality17
- Growth12.5
- Financials14.5
- Risk13.2
Neutral
All stock scores →ETF
ETFs holding it in their top 10 · recent changes10/08 이후 큰 ETF 변화는 없어요
ETFs holding the most
- KoAct 바이오헬스케어 Active7.4%
Recent filings
DART- Loading
Broker price targets
Recent 1YAvg642,500
High730,000
Low500,000
| Broker | Rating | Target | vs prior | Date |
|---|---|---|---|---|
| Kyobo Securities | Buy | 700,000 | Unch. | 26.10.16 |
| Yuanta Securities Korea하OO | Buy | 700,000 | Unch. | 26.10.14 |
| Kiwoom Securities | Buy | 710,000 | ▼3% | 26.10.14 |
| Hana Securities | Buy | 660,000 | Unch. | 26.10.14 |
| iM Securities | Buy | 650,000 | ▲8% | 26.10.08 |
| Samsung Securities | Buy | 650,000 | ▲16% | 26.09.23 |
| Shinhan Securities | Buy | 650,000 | ▲27% | 26.08.27 |
| DS Securities | Buy | 720,000 | ▲6% | 26.08.25 |
| IBK Securities | Buy | 530,000 | Unch. | 26.08.25 |
| Mirae Asset Securities | Buy | 730,000 | ▲14% | 26.08.25 |
| Eugene Investment & Securities | Buy | 510,000 | ▲34% | 25.11.03 |
| Daishin Securities | Buy | 500,000 | ▲11% | 25.10.28 |
Recent reports
- 3Q26 Preveiw: 계약금 이연으로 Earnings 일시적 휴식Kyobo Securities · 10/16
- L/O 계약금 인식 지연Yuanta Securities Korea · 10/14
- Q3 하회 전망되나, Q4 기대Kiwoom Securities · 10/14
- 더 안정적인 Growth 위한 정비 작업(3Q26 Pre)Hana Securities · 10/14
- 펩타이드의 이야기, AI 다시 쓰다iM Securities · 10/08
Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked
Same sector
HanmiPharm summary
HanmiPharm (128940). Pension funds: +₩22.8B over the last 20 trading days; 2-day net selling streak. Market cap ₩5.03T, PER 23.17×, PBR 3.55×. Avg. analyst target ₩678,235. Pension flows are based on Korea Exchange investor statistics, for reference only.